Mizuho Upgrades Boston Scientific to Buy, Announces $80 Price Target
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone upgraded Boston Scientific (NYSE:BSX) from Neutral to Buy and set a new price target of $80. This represents a positive outlook on the company's future performance.
February 01, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific was upgraded by Mizuho from Neutral to Buy with a new price target of $80, indicating a positive future outlook.
The upgrade from Neutral to Buy by a reputable analyst at Mizuho, along with a significant price target of $80, suggests a strong confidence in Boston Scientific's future performance. This is likely to positively influence investor sentiment and potentially lead to an increase in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100